#USA #Dallas #Newton #Sequel Lens #VSP

Celebrating Comfort and Clarity with Sequel

In a significant stride for eye care, Newton has recently announced the inclusion of its new Sequel lens in VSP's managed vision care plan. Known for its innovative eye care solutions, Newton aims to make its groundbreaking Convergence Boost technology available to a wider audience. The Sequel lens addresses the growing issue of digital eye strain, which affects nearly 75% of users in today’s screen-centric world.

The Rise of Digital Eye Strain

The digital age has transformed the way we live and interact with technology. However, it has also given rise to a common complaint: digital eye strain. Symptoms like discomfort, fatigue, and blurred vision can significantly impact daily life, making it essential for those affected to seek effective solutions. With the introduction of Sequel, Newton aims to tackle this problem head-on. The lens has been specifically designed to combat the challenges of our modern visual demands, providing unparalleled comfort and clarity.

Convergence Boost Technology

At the heart of the Sequel lens is its patented Convergence Boost technology. This innovative feature has been demonstrated to halve the symptoms associated with digital eye strain. Variables like prolonged computer use, smartphone engagement, and other digital interactions can lead to severe discomfort for many users. Sequel users have reported significant relief, and studies indicate that 91% of wearers see a reduction in strain-related issues.

VSP Inclusion: A Game Changer

The inclusion of Sequel in VSP's managed vision care plan marks a pivotal moment in the accessibility of advanced optical solutions. Previously considered a premium option, Sequel is now available to the millions of patients enrolled in VSP, thus democratizing access to quality eye care. This partnership not only enhances the vision care experience within the VSP network but also empowers optometric practices with a remarkable solution that is swift to dispense and produces impressive results.

A Testament to Impact

Davis Corley, CEO of Newton, emphasized the transformative nature of this collaboration, stating, "Sequel is the lens patients didn't know they needed—but won't want to go without. With VSP inclusion, we're democratizing access to patented technology that works for the way we live now. VSP availability removes barriers and puts life-changing vision solutions within reach of millions."

Optometrists fitting the Sequel lens have reported remarkable feedback from patients, describing a newfound sense of refreshment and relaxation. Dr. Paul Lovero, an optometrist who has embraced the Sequel lens in his practice, reflects the sentiment of many, noting that patients express feeling as if their eyes are "on vacation"—relieved of strain and discomfort.

Sequel's Design Variants

The Sequel lens portfolio includes several variations designed to cater to different visual needs—specifically Sequel 0, 38, 67, and PAL designs. Each variant maintains the channel of Convergence Boost technology, ensuring that a broad spectrum of patients can benefit from relief against digital eye strain.

The Vision Ahead

With its rich history of innovation and a firm commitment to enhancing eye care, Newton is eager to expand its lens portfolio with Sequel. While Neurolenses with Contoured Prism technology remain a premium offering, the introduction of Sequel presents an everyday option for maintaining eye health. This demonstrates Newton's dedication to not just serving patients with eye care solutions but also elevating the standards of the industry.

In conclusion, the launch of Sequel through VSP signifies a monumental step in addressing the critical issue of digital eye strain. As patients gain access to this revolutionary lens, the future looks bright—not just for eye care, but for everyone who can reclaim their visual comfort.

To discover more about Sequel and how its introduction within VSP can benefit your practice and patients, visit www.sequellens.com.